Literature DB >> 17597410

Omeprazole inhibits natural killer cell functions.

Huseyin Alkim1, Selahattin Unal, Hamza Okur, Turgut Imir.   

Abstract

This study was designed to determine the possible effects of omeprazole on human natural killer cells. Peripheral venous blood samples were taken from 20 peptic ulcer patients before and at the 14th and the 28th days of omeprazole treatment. Mononuclear cells were removed from blood and their capability of making conjugation with K562 target cells and lysing K562 target cells was evaluated. A significant decrease was found (P < 0.001) in the 14th and the 28th days compared with the basal value of the capability of the mononuclear cells to conjugate with the K562 target cells and to lyse them. This study demonstrated that omeprazole significantly reduces natural killer cell functions. This finding suggests that omeprazole may also have some effects on the other systems in addition to parietal cell acid secretion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597410     DOI: 10.1007/s10620-007-9869-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Omeprazole for duodenal ulceration in Crohn's disease.

Authors:  R M Valori; R Cockel
Journal:  BMJ       Date:  1990-02-17

Review 2.  The gastric H+,K+-ATPase: the site of action of omeprazole.

Authors:  G Sachs; B Wallmark
Journal:  Scand J Gastroenterol Suppl       Date:  1989

Review 3.  Proton atpases: structure and mechanism.

Authors:  L M Amzel; P L Pedersen
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

Review 4.  Lysosomes revisited.

Authors:  C de Duve
Journal:  Eur J Biochem       Date:  1983-12-15

5.  Evidence of a dynamic role of the target cell membrane during the early stages of the natural killer cell lethal hit.

Authors:  R L Deem; S R Targan
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

Review 6.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

7.  Omeprazole attenuates neutrophil-endothelial cell adhesive interaction induced by extracts of Helicobacter pylori.

Authors:  M Suzuki; M Mori; D Fukumura; H Suzuki; S Miura; H Ishii
Journal:  J Gastroenterol Hepatol       Date:  1999-01       Impact factor: 4.029

8.  Rabeprazole treatment attenuated Helicobacter pylori-associated gastric mucosal lesion formation in Mongolian gerbils.

Authors:  Hidekazu Suzuki; Masaharu Miyazawa; Shoichi Nagahashi; Masaru Sato; Motoaki Bessho; Hiroshi Nagata; Soichiro Miura; Hiromasa Ishii
Journal:  J Gastroenterol Hepatol       Date:  2003-07       Impact factor: 4.029

Review 9.  A view of acidic intracellular compartments.

Authors:  R G Anderson; L Orci
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

10.  Recycling and target binding capacity of human natural killer cells.

Authors:  M Ullberg; M Jondal
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  3 in total

1.  Therapy with omeprazole modulates regulatory T cell/T helper 17 immune response in children with duodenal ulcers.

Authors:  Chuan-Ying Li; Cheng Wu
Journal:  Inflammopharmacology       Date:  2017-07-22       Impact factor: 4.473

2.  Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.

Authors:  Sascha Dublin; Rod L Walker; Michael L Jackson; Jennifer C Nelson; Noel S Weiss; Lisa A Jackson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-08       Impact factor: 2.890

3.  The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice.

Authors:  Scott A Sands; Sheila Tsau; Thomas M Yankee; Brooks L Parker; Aaron C Ericsson; Steven M LeVine
Journal:  BMC Res Notes       Date:  2014-09-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.